Alzheimer’s disease at the early stage is usually indicated by mild memory loss. It is the progression of the disease that results in the detrimental memory loss we associate with Alzheimer’s disease. Though age plays a factor in Alzheimer’s disease, the accelerated deterioration of brain function is the ultimate problem. Michela Gallagher, Krieger-Eisenhower Professor of Psychological and Brain Sciences in the Krieger School of Arts and Sciences at Johns Hopkins, shares information about Alzheimer’s and one possible way to slow the advancement of Alzheimer’s.
An existing drug used to prevent seizures has been documented to improve memory. The drug is beneficial to slow abnormal loss of brain function; it is a potential treatment for Azheimer’s disease that will help patients maintain more brain function as the disease progresses.